Companies: 10,795·Total market cap: $144.5T
Eli Lilly and Company

Eli Lilly and Company

LLY.TOTSXHealthcare● Active
$40.68
+$0.22(+0.54%)
Market Cap$1.40T
P/E Ratio—
52W High$41.89
52W Low$30.67
PE RatioMarket CapForecast

Eli Lilly and Company (LLY.TO) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

lly.to · pe ratio · data through Jun 8, 2026

Core PE Ratio Metrics

Trailing 12 months · TTM

Insufficient PE history data (fewer than 3 valid fiscal years).

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Eli Lilly and Company (LLY.TO) measures how much investors pay for each dollar of the company's trailing earnings. LLY.TO's current PE ratio of 40.04x is calculated by dividing its stock price of $40.68 by its TTM earnings per share of $28.26.

PE Ratio = Stock Price ÷ EPS (TTM)
= $40.68 ÷ $28.26 = 40.04x
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.
Price historyFinancial statementsEarnings

Frequently asked questions

LLY.TO pe ratio · 6 questions

LLY.TO's current PE ratio is 40.04x as of 2026-06-08, based on a stock price of $40.68 and TTM EPS of $28.26. Data sourced from Financial Modeling Prep via LLY.TO's SEC 10-K and 10-Q filings.

LLY.TO PE ratioWhat is LLY.TO PE ratioCurrent PE ratio of LLY.TOLLY.TO PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Eli Lilly and Company SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08